The role of complement in B cell activation and tolerance.

It is becoming well accepted that innate immunity serves as a natural adjuvant in enhancing and directing the adaptive immune response. In this review, I have discussed how the complement system, a major mediator of innate immunity, links the two systems. The recent availability of knockout mice bearing selective deficiencies in the critical complement proteins and receptors has allowed formal demonstration of the importance of complement in enhancement of humoral immunity. Characterization of the mice has also uncovered mechanisms for maintaining survival of activated B cells within the lymphoid compartment. For example, co-ligation of the CD21/CD19/Tapa-1 receptor with the BCR not only reduces the threshold for B cell follicular survival but provides a unique signal for survival in the germinal centers. In addition complement receptors are critical for localization of antigen and C3d ligand to FDCs for maintenance of long-term B cell memory. A surprise that has come from analysis of the deficient mice is that complement is also important in negative selection of B lymphocytes. This observation provides new insight to a long-standing enigma that the major predisposing factor in lupus is deficiency in complement C1q or C4. The seeming contradiction of dual role for complement in both B cell activation and tolerance is reconciled by the hypothesis that natural IgM provides a mechanism to selectively identify self-antigens that are highly conserved and cross-react with microbial ones such as DNA and nuclear proteins. Thus, the importance of complement in tolerance to self-antigens is restricted to those self-antigens that are evolutionary conserved, and they are identified by natural antibody. The future should hold further surprises as to the intricate interactions between the complement system and acquired immunity.

[1]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[2]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[3]  R. Hardy,et al.  The site and stage of anti-DNA B-cell deletion , 1995, Nature.

[4]  S. Smith‐Gill,et al.  Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. , 1992, Journal of immunology.

[5]  S. Ju,et al.  Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells , 1995, Nature.

[6]  D. Fearon,et al.  CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. , 1998, Immunity.

[7]  D. Gray,et al.  T Cell–dependent Immune Response in C1q-deficient Mice: Defective Interferon γ Production by Antigen-specific T Cells , 1998, The Journal of experimental medicine.

[8]  M. Carroll,et al.  Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. , 1998, Journal of immunology.

[9]  M. Thomas,et al.  Evidence for presence of an internal thiolester bond in third component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Reid,et al.  The proteolytic activation systems of complement. , 1981, Annual review of biochemistry.

[11]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[12]  V. Nussenzweig,et al.  Receptors for C3 on B Lymphocytes: Possible Role in the Immune Response , 1971 .

[13]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[14]  H. Ochs,et al.  Complement, membrane glycoproteins, and complement receptors: their role in regulation of the immune response. , 1986, Clinical immunology and immunopathology.

[15]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[16]  G. Kelsoe,et al.  Antibody response to a T-dependent antigen requires B cell expression of complement receptors , 1996, The Journal of experimental medicine.

[17]  J. Banchereau,et al.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes , 1995, The Journal of experimental medicine.

[18]  V. Holers,et al.  A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. , 1990, Journal of immunology.

[19]  B. Heyman,et al.  Complement activation is required for IgM-mediated enhancement of the antibody response , 1988, The Journal of experimental medicine.

[20]  J. Schifferli,et al.  The role of complement and its receptor in the elimination of immune complexes. , 1986, The New England journal of medicine.

[21]  A. Yamada,et al.  DEFECTIVE IMMUNE-ADHERENCE (C3b) RECEPTOR ON ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 1981, The Lancet.

[22]  K. Shokat,et al.  Antigen-induced B-cell death and elimination during germinal-centre immune responses , 1995, Nature.

[23]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[24]  J. Ahearn,et al.  C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. , 1997, Journal of immunology.

[25]  M. Cuccia,et al.  Structural differences between the two human complement C4 isotypes affect the humoral immune response , 1992, The Journal of experimental medicine.

[26]  L. Herzenberg,et al.  Origin of murine B cell lineages. , 1993, Annual review of immunology.

[27]  D. Pisetsky,et al.  A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. , 1990, Arthritis and rheumatism.

[28]  T. Mak,et al.  Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45 , 1996, Nature.

[29]  G. Kelsoe.  The germinal center reaction. , 1995, Immunology today.

[30]  E. Tan,et al.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. , 1982, Advances in immunology.

[31]  L. Elveback,et al.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. , 1985, Mayo Clinic proceedings.

[32]  D. Fearon,et al.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. , 1992, Science.

[33]  J. Tew,et al.  Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro. , 1996, Journal of immunology.

[34]  F. Burnet.  The clonal selection theory of acquired immunity , 1959 .

[35]  V. Vetvicka,et al.  Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. , 1994, Journal of immunology.

[36]  T. Manser,et al.  Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response. , 1997, Journal of immunology.

[37]  Mark M. Davis,et al.  CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells , 1995, Nature.

[38]  S. Sato,et al.  CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Köhler,et al.  Transitional B cells are the target of negative selection in the B cell compartment , 1995, The Journal of experimental medicine.

[40]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self- tolerance , 1995, The Journal of experimental medicine.

[41]  Klaus Rajewsky,et al.  Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.

[42]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[43]  R. Levine,et al.  Covalent binding and hemolytic activity of complement proteins. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Kozono,et al.  Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. , 1988, Journal of immunology.

[45]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[46]  J. Monroe,et al.  Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. , 1995, Journal of immunology.

[47]  S. Christensen,et al.  The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. , 1990, Journal of immunology.

[48]  C. Goodnow,et al.  Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. , 1994, International immunology.

[49]  V. Agnello.  Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. , 1978, Arthritis and rheumatism.

[50]  J. Cyster,et al.  Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. , 1995, Immunity.

[51]  C. Goodnow,et al.  Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens , 1991, Nature.

[52]  M. Retter,et al.  Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. , 1998, Immunity.

[53]  C. Goodnow,et al.  A critical role for complement in maintenance of self-tolerance. , 1998, Immunity.

[54]  G. Klaus,et al.  The Follicular Dendritic Cell: Its Role in Antigen Presentation in the Generation of Immunological Memory , 1980, Immunological reviews.

[55]  S. Sheriff,et al.  The collectins in innate immunity. , 1996, Current opinion in immunology.

[56]  V. Nussenzweig,et al.  Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1). , 1985, Journal of immunology.

[57]  D. Fearon,et al.  Binding of C3b and C4b by the CR1-like site in murine CR1. , 1994, Journal of immunology.

[58]  V. M. Holers,et al.  Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. , 1997, Journal of immunology.

[59]  C. Goodnow.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Carroll,et al.  Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. , 1998, Journal of immunology.

[61]  D. Fearon,et al.  Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). , 1989, Advances in immunology.

[62]  A. Theofilopoulos,et al.  Murine models of systemic lupus erythematosus. , 1985, Advances in immunology.

[63]  E. Holborow,et al.  Complement Dependence of Localisation of Aggregated IgG in Germinal Centres , 1975, Scandinavian journal of immunology.

[64]  V. Holers,et al.  Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. , 1998, Journal of immunology.

[65]  Jeffrey Crosbie,et al.  Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.

[66]  C. Goodnow,et al.  CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes , 1997, The Journal of experimental medicine.

[67]  M. Pepys.  Role of complement in induction of the allergic response. , 1972, Nature: New biology.

[68]  M. Carroll,et al.  The lupus paradox , 1998, Nature Genetics.

[69]  Liangji Zhou,et al.  The CD19/CD21 signal transduction complex of B lymphocytes. , 1994, Immunology today.

[70]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[71]  D. Nemazee,et al.  Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Walport,et al.  Complement deficiency and disease. , 1991, Immunology today.

[73]  E. Kremmer,et al.  Regulation of the B cell response to T-dependent antigens by classical pathway complement. , 1996, Journal of immunology.

[74]  L. Mandik-Nayak,et al.  Regulation of Anti–double-stranded DNA B Cells in Nonautoimmune Mice: Localization to the T–B Interface of the Splenic Follicle , 1997, The Journal of experimental medicine.

[75]  D. Fearon,et al.  Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1 , 1988, The Journal of experimental medicine.

[76]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[77]  G. Kelsoe,et al.  Dependence of germinal center B cells on expression of CD21/CD35 for survival. , 1998, Science.

[78]  B. Koller,et al.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.

[79]  J. Monroe,et al.  Acquisition of surface IgD fails to protect from tolerance-induction. Both surface IgM- and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes. , 1996, Journal of immunology.

[80]  V. Holers,et al.  Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. , 1994, Journal of immunology.

[81]  D. Fearon,et al.  Complement ligand-receptor interactions that mediate biological responses. , 1983, Annual review of immunology.

[82]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[83]  Kenneth G. C. Smith,et al.  Soluble antigen can cause enhanced apoptosis of germinal-centre B cells , 1995, Nature.

[84]  H. Müller-Eberhard,et al.  Molecular organization and function of the complement system. , 1988, Annual review of biochemistry.

[85]  G. Nossal.  Cellular mechanisms of immunologic tolerance. , 1983, Annual review of immunology.

[86]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[87]  M. Thomas,et al.  Sequence determination of the thiolester site of the fourth component of human complement. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Cooke,et al.  Self-tolerance checkpoints in B lymphocyte development. , 1995, Advances in immunology.

[89]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[90]  D. Fearon,et al.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. , 1995, Annual review of immunology.